You just read:

Regeneron and Sanofi Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union

News provided by

Regeneron Pharmaceuticals, Inc.

Jun 27, 2017, 01:00 ET